Federal Register / Vol. 76, No. 32 / Wednesday, February 16, 2011 / Notices 9031 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 10, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–3483 Filed 2–15–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: March 11, 2011. 

Time: 11:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Camilla E. Day, PhD, 

Scientific Review Officer, CIDR, National 

Human Genome Research Institute, National 

Institutes of Health, 5635 Fishers Lane, Suite 

4075, Bethesda, MD 20892, 301–402–8837, 

camilla.day@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: February 10, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–3482 Filed 2–15–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIAMS. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIAMS. 

Date: March 3–4, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate the 

Molecular Immunology and Inflammation 

Branch and the Laboratory of Skin Biology. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 4C32, Bethesda, MD 20892. 

Contact Person: John J. O’Shea, MD, PhD, 

Scientific Director, National Institute of 

Arthritis & Musculoskeletal and Skin 

Diseases, Building 10, Room 9N228, MSC 

1820, Bethesda, MD 20892, (301) 496–2612, 

osheaj@arb.niams.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: February 9, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–3481 Filed 2–15–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Library of 

Medicine Special Emphasis Panel R25. 

Date: March 16, 2011. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20817 (Telephone Conference Call). 

Contact Person: Zoe H. Huang, MD, 

Scientific Review Officer, Extramural 

Programs, National Library of Medicine, NIH, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892–7968, 301–594–4937, 

huangz@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: February 10, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–3480 Filed 2–15–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; CDRC 

Member Conflicts Review. 

Date: March 9, 2011. 

Time: 10:30 a.m. to 1 p.m. 

mstockstill on DSKH9S0YB1PROD with NOTICES

9032 Federal Register / Vol. 76, No. 32 / Wednesday, February 16, 2011 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Christine A. Livingston, 

PhD, Scientific Review Officer, Division of 

Extramural Activities, National Institutes of 

Health/NIDCD, 6120 Executive Blvd.—MSC 

7180, Bethesda, MD 20892, (301) 496–8683, 

livingsc@mail.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Autism 

Supplements. 

Date: March 24, 2011. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Susan L. Sullivan, PhD, 

Scientific Review Officer, National Institute 

of Deafness and Other Communication 

Disorders, 6120 Executive Blvd., Ste. 400C, 

Rockville, MD 20852, (301) 496–8683, 

sullivas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: February 10, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–3479 Filed 2–15–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration will publish 

periodic summaries of proposed 

projects. To request more information 

on the proposed projects or to obtain a 

copy of the information collection 

plans, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, through the use of 

automated collection techniques or 

other forms of information technology. 

Proposed Project: Protection and 

Advocacy for Individuals With Mental 

Illness (PAIMI) Annual Program 

Performance Report (OMB No. 0930– 

0169)—Revision 

The Protection and Advocacy for 

Individuals with Mental Illness (PAIMI) 

Act at 42 U.S.C. 10801 et seq., 

authorized funds to the same protection 

and advocacy (P&A) systems created 

under the Developmental Disabilities 

Assistance and Bill of Rights Act of 

1975, known as the DD Act (as amended 

in 2000, 42 U.S.C. 15041 et seq.). The 

DD Act supports the Protection and 

Advocacy for Developmental 

Disabilities (PADD) Program 

administered by the Administration on 

Developmental Disabilities (ADD) 

within the Administration on Children 

and Families. ADD is the lead Federal 

P&A agency. The PAIMI Program 

supports the same governor-designated 

P&A systems established under the DD 

Act by providing legal-based individual 

and systemic advocacy services to 

individuals with significant (severe) 

mental illness (adults) and significant 

(severe) emotional impairment 

(children/youth) who are at risk for 

abuse, neglect and other rights 

violations while residing in a care or 

treatment facility. 

In 2000, the PAIMI Act amendments 

created a 57th P&A system—the 

American Indian Consortium (the 

Navajo and Hopi Tribes in the Four 

Corners region of the Southwest). The 

Act, at 42 U.S.C. 10804(d) states that a 

P&A system may use its allotment to 

provide representation to individuals 

with mental illness, as defined by s42 

U.S.C. 10802 (4)(B)(iii) residing in the 

community, including their own home, 

only, if the total allotment under this 

title for any fiscal year is $30 million or 

more, and in such cases an eligible P&A 

system must give priority to 

representing PAIMI-eligible individuals, 

as defined by 42 U.S.C. 10802(4)(A) and 

(B)(i). 

The Children’s Health Act of 2000 

(CHA) also referenced State P&A system 

authority to obtain information on 

incidents of seclusion, restraint and 

related deaths [see, CHA, Part H at 42 

U.S.C. 290ii–1]. PAIMI Program formula 

grants awarded by SAMHSA go directly 

to each of the 57 governor-designated 

P&A systems. These systems are located 

in each of the 50 states, the District of 

Columbia, the American Indian 

Consortium, and five (5) territories— 

American Samoa, Guam, the 

Commonwealth of the Northern Mariana 

Islands, the Commonwealth of Puerto 

Rico, and the U.S. Virgin Islands. 

The PAIMI Act at 42 U.S.C. 10805(7) 

requires that each P & A system prepare 

and transmit to the Secretary HHS and 

to the head of its State mental health 

agency a report on January 1. This 

report describes the activities, 

accomplishments, and expenditures of 

the system during the most recently 

completed fiscal year, including a 

section prepared by the advisory 

council (the PAIMI Advisory Council or 

PAC) that describes the activities of the 

council and its assessment of the 

operations of the system. 

The Substance Abuse Mental Health 

Services Administration (SAMHSA) 

proposes to revise the annual PAIMI 

Program Performance Report (PPR), 

including the advisory council section 

of the report for the following reasons: 

(1) To make it consistent with the r 

annual reporting requirements under 

the Act and its Rules [42 CFR part 51], 

(2) to conform to the GPRA 

requirements that SAMHSA obtain 

information that closely measures actual 

outcomes of programs that are funded 

by the agency, and (3) to determine if 

the reporting burden can be reduced by 

removing any information that does not 

facilitate evaluation of the programmatic 

and fiscal effectiveness of a State P&A 

system. 

The SAMHSA revisions to the annual 

PPR and Advisory Council section 

reflect the statutory and regulatory 

requirements of the PAIMI Act. These 

revisions include, but may not be 

limited to the following items: (1) 

Clarifying the instructional guidance in 

the PPR, e.g., Section 3.—Living 

Arrangements; Section 4—Complaints/ 

Problems of PAIMI-eligible Individuals, 

at 4. D.2.—Intervention Strategy 

Outcome Statement, by using a chart 

format to capture the most significant 

outcome achieved per strategy used; 

eliminating the need for attachments, 

i.e., in Section 7—Grievance 

Procedures, a copy of the policies/ 

procedures, in Section 8—Other 

Services and Activities a copy of agency 

policies/procedures for obtaining 

comments from the public (8.A.3.), and 

a copy of the public comment 

opportunity notice (8.A.1.); (2) 

clarifying the Advisory Council section 

of the PPR, e.g., Section B. PAIMI 

Advisory Council Membership, 

secondary identification instructions; 

and, (3) eliminating the submission of 

supplemental documents, e.g., PAIMI 

bylaws, etc. The revised report formats 

mstockstill on DSKH9S0YB1PROD with NOTICES